
Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment
Highlights Summary Immunosuppressive tumor microenvironments (TMEs) reduce the effectiveness of immune responses in cancer. Mesenchymal stromal cells (MSCs), precursors to cancer-associated fibroblasts (CAFs), promote tumor